Ardent Health Partners, LLC (ARDT)
Automate Your Wheel Strategy on ARDT
With Tiblio's Option Bot, you can configure your own wheel strategy including ARDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ARDT
- Rev/Share 44.9995
- Book/Share 11.6088
- PB 1.1023
- Debt/Equity 1.8378
- CurrentRatio 2.0754
- ROIC 0.1545
- MktCap 1390352383.0
- FreeCF/Share 1.1019
- PFCF 8.9765
- PE 6.6563
- Debt/Assets 0.4415
- DivYield 0
- ROE 0.1709
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ARDT | KeyBanc Capital Markets | Overweight | Sector Weight | -- | -- | Nov. 17, 2025 |
| Downgrade | ARDT | Morgan Stanley | Overweight | Equal Weight | -- | -- | Nov. 14, 2025 |
| Initiation | ARDT | Goldman | -- | Neutral | -- | $19 | Oct. 14, 2025 |
| Initiation | ARDT | UBS | -- | Buy | -- | $17 | Sept. 10, 2025 |
| Downgrade | ARDT | BofA Securities | Neutral | Underperform | -- | $14.6 | July 16, 2025 |
| Resumed | ARDT | JP Morgan | -- | Neutral | -- | $20 | Dec. 17, 2024 |
| Initiation | ARDT | KeyBanc Capital Markets | -- | Overweight | -- | $24 | Oct. 11, 2024 |
News
ARDT BREAKING: Ardent Health, Inc. Revenue Drop Triggers Securities Fraud Investigation after Stock Plummets 33% -- Investors Urged to Contact BFA Law
Published: November 13, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $ARDT #ARDT--Ardent Health, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
Read More
Ardent Health, Inc. (ARDT) Q3 2025 Earnings Call Transcript
Published: November 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Ardent Health, Inc. ( ARDT ) Q3 2025 Earnings Call November 13, 2025 9:00 AM EST Company Participants David Styblo - Senior Vice President of Investor Relations Martin Bonick - President, CEO & Director Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Jason Cassorla - Guggenheim Securities, LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Kevin Fischbeck - BofA Securities, Research Division Zach Haggerty Raj Kumar - Stephens Inc., Research Division Craig Hettenbach - Morgan Stanley, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Benjamin …
Read More
Ardent Health, Inc. (NYSE: ARDT) Investigation Alert: Johnson Fistel Reviews Accounting Adjustment and Liability Reserve Increase Following Stock Drop
Published: November 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Ardent Health, Inc. (NYSE: ARDT) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors.
Read More
Ardent Health, Inc. (ARDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Published: September 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Ardent Health, Inc. (NYSE:ARDT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:45 AM EDT Company Participants Martin Bonick - President, CEO & Director Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. Great. Good morning, everyone.
Read More
Ardent Health: The Best Prospect In An Industry That's Facing Challenges
Published: July 17, 2025 by: Seeking Alpha
Sentiment: Negative
Ardent Health faces significant legislative risks, due to Medicaid and Medicare cuts, causing uncertainty and a recent downgrade, but much of this is priced in. Despite headwinds, Ardent Health demonstrates strong revenue and profitability growth, low leverage, and trades at compellingly cheap valuations, versus peers. Management projects continued growth for 2025, with revenue and EBITDA expected to rise, supported by higher-margin service expansions and acquisitions.
Read More
Wall Street Analysts Predict a 36.55% Upside in Ardent Health Partners, Inc. (ARDT): Here's What You Should Know
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Ardent Health Partners, Inc. (ARDT) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
Ardent Health Reports First Quarter 2025 Results
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of.
Read More
Ardent Health Reports Fourth Quarter 2024 Results
Published: February 26, 2025 by: Business Wire
Sentiment: Neutral
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics belo.
Read More
About Ardent Health Partners, LLC (ARDT)
- IPO Date 2024-07-18
- Website https://www.ardenthealth.com
- Industry Medical - Care Facilities
- CEO Martin J. Bonick
- Employees 19200